Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
65,434,344
-
Share change
-
-3,348,785
-
Total reported value
-
$11,201,090
-
Price per share
-
$0.18
-
Number of holders
-
38
-
Value change
-
-$1,254,198
-
Number of buys
-
13
-
Number of sells
-
32
Institutional Holders of RUBIUS THERAPEUTICS INC - COM (RUBY) as of Q4 2022
As of 31 Dec 2022,
RUBIUS THERAPEUTICS INC - COM (RUBY) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,434,344 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, BAILLIE GIFFORD & CO, Artal Group S.A., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., HarbourVest Partners LLC, STATE OF MICHIGAN RETIREMENT SYSTEM, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.